SVCM
Saturn V Capital Management Portfolio holdings
AUM
$247M
This Quarter Return
+1.32%
1 Year Return
+2.68%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$134M
AUM Growth
+$134M
(+11%)
Cap. Flow
+$3.13M
Cap. Flow
% of AUM
2.34%
Top 10 Holdings %
Top 10 Hldgs %
78.52%
Holding
20
New
1
Increased
10
Reduced
7
Closed
2
Top Buys
| 1 |
Biogen
BIIB
|
$8.29M |
| 2 |
BioCryst Pharmaceuticals
BCRX
|
$6.87M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$3.28M |
| 4 |
KalVista Pharmaceuticals
KALV
|
$3.16M |
| 5 |
Cytokinetics
CYTK
|
$3.02M |
Top Sells
| 1 |
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
|
$6.86M |
| 2 |
Apellis Pharmaceuticals
APLS
|
$5.88M |
| 3 |
TSVT
2seventy bio
TSVT
|
$5.23M |
| 4 |
Amicus Therapeutics
FOLD
|
$3.41M |
| 5 |
Arcutis Biotherapeutics
ARQT
|
$3.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBAY
1
DELISTED
Cymabay Therapeutics
CBAY
| $14.2M | 10.61% | 1,629,464 +17,686 | +1% | +$154K |
|
2
Crinetics Pharmaceuticals
CRNX
$2.92B
| $11.9M | 8.89% | 741,043 +117,224 | +19% | +$1.88M |
|
|
KDNY
3
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $11.7M | 8.76% | 506,818 +83,641 | +20% | +$1.94M |
|
|
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $10.8M | 8.09% | 99,217 +30,047 | +43% | +$3.28M |
|
|
5
Biogen
BIIB
$19.4B
| $10.4M | 7.78% | 37,459 +29,799 | +389% | +$8.29M |
|
|
6
Cytokinetics
CYTK
$4.23B
| $9.95M | 7.44% | 282,886 +85,904 | +44% | +$3.02M |
|
|
7
BioCryst Pharmaceuticals
BCRX
$1.74B
| $9.7M | 7.25% | 1,163,535 +823,372 | +242% | +$6.87M |
|
|
MORF
8
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $9.28M | 6.93% | 246,616 -23,211 | -9% | -$874K |
|
|
9
KalVista Pharmaceuticals
KALV
$678M
| $8.82M | 6.59% | 1,121,982 +402,045 | +56% | +$3.16M |
|
10
Ascendis Pharma
ASND
$11.8B
| $8.28M | 6.18% | 77,210 +8,806 | +13% | +$944K |
|
|
11
Apellis Pharmaceuticals
APLS
$3.48B
| $8.12M | 6.07% | 123,165 -89,164 | -42% | -$5.88M |
|
12
iTeos Therapeutics
ITOS
| $6.54M | 4.89% | 480,653 +138,582 | +41% | +$1.89M |
|
|
SAGE
13
DELISTED
Sage Therapeutics
SAGE
| $6.08M | 4.54% | 145,018 -11,067 | -7% | -$464K |
|
|
14
Amicus Therapeutics
FOLD
$2.34B
| $2.86M | 2.14% | 258,288 -307,891 | -54% | -$3.41M |
|
|
15
Arcutis Biotherapeutics
ARQT
$1.86B
| $1.96M | 1.46% | 178,217 -308,962 | -63% | -$3.4M |
|
|
TSVT
16
DELISTED
2seventy bio
TSVT
| $1.76M | 1.31% | 172,188 -512,808 | -75% | -$5.23M |
|
17
Astria Therapeutics
ATXS
$349M
| $1.35M | 1.01% | 101,339 -68,154 | -40% | -$906K |
|
18
Scilex Holding
SCLX
$124M
| $85.2K | 0.06% | +10,390 | New | +$85.2K |
|
19
Theravance Biopharma
TBPH
$699M
| – | – | -141,339 | Closed | -$1.33M |
|
|
ALBO
20
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| – | – | -341,827 | Closed | -$6.86M |
|